Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Effect of ether glycerol lipids on interleukin-1β release and experimental autoimmune encephalomyelitis.
Role of Subventricular Zone Derived Neural Precursor Cells in the Therapy of Experimental Autoimmune Encephalomyelitis.
Adherence and Persistence among Patients Treated with First-Line Therapies for Relapsing-Remitting Multiple Sclerosis in Brazil.
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.
The Fluctuating Natural Course of CCSVI in MS Patients and Controls, a Prospective Follow-Up.
A multicentre prospective study of Guillain-Barre Syndrome in Japan: a focus on the incidence of subtypes.
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
Single-step grafting of aminooxy-peptides to hyaluronan: A simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.
Comparison of ActiGraph activity monitors in persons with multiple sclerosis and controls.
Variants in the promoter region of CYP7A1 are associated with neuromyelitis optica but not with multiple sclerosis in the Han Chinese population.
Potential pathogens in multiple sclerosis (MS.
Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria.
Temporal filtering of longitudinal brain magnetic resonance images for consistent segmentation.
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
Current and Emerging Therapies for Multiple Sclerosis.
[The usefulness of 3T magnetic resonance in the differential diagnosis of ischemic optic neuropathy and inflammatory optic neuritis].
Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).
The ideal healthcare: priorities of people with chronic conditions and their carers.
Making myelin basic protein -from mRNA transport to localized translation.
Alterations of brain eicosanoid synthetic pathway in multiple sclerosis and in animal models of demyelination: Role of cyclooxygenase-2.
Accumulation of Fascin+ cells during experimental autoimmune neuritis.
Brain reserve and cognitive reserve in multiple sclerosis: What you've got and how you use it.
Preface: Perspectives of an MS Researcher.

Pages